Skip to main content

223.687.98
Vaccine Policy Issues

Location
Barcelona, Spain
Term
2nd Term
Department
International Health
Credit(s)
3
Academic Year
2012 - 2013
Instruction Method
TBD
Start Date
Thursday, November 15, 2012
End Date
Saturday, November 17, 2012
Class Time(s)
Th, F, Sa, 8:30am - 6:00pm
Auditors Allowed
No
Available to Undergraduate
No
Grading Restriction
Letter Grade or Pass/Fail
Course Instructor(s)
Contact Name
Frequency Schedule
One Year Only
Next Offered
Only offered in 2012
Prerequisite

223.662, Vaccine Development and Application

Description
Examines current national and international policy issues in vaccine research, development, manufacturing, supply, and utilization. Topics include development of orphan vaccines, ensuring an adequate supply of safe and effective vaccines, vaccine injury compensation, and disease eradication. Emphasizes the identification of important vaccine policy issues and the development and evaluation of policies to address these issues. Presents the roles, responsibilities, and policy positions of key immunization stakeholders via guest lectures by a wide array of experts who have worked for important vaccine groups (i.e., FDA, GAVI, Vaccine Industry, US Vaccine Injury Compensation Program, Consumer Group). Readings include relevant scientific papers and reviews, and publications of U.S. and international agencies.
Learning Objectives
Upon successfully completing this course, students will be able to:
  1. identify the key stakeholders and institutions involved in formulating vaccine policy in the United States and globally
  2. describe the 'value chain' in vaccine policy domestically and globally as it progresses from basic research all the way to procurement and implementation
  3. describe the different factors that influence the policy-makers in each stage of the 'value chain' and the factors that constrain their ability to enact policy changes
  4. use a 'policy analysis' perspective to analyze a vaccine policy issue and recommend a policy action